在克罗恩氏病患者中甲醇单一治疗的有效性和耐受性:一项多中心观察性研究
Jihye Park1,2, Jaeyoung Chun3, Soo Jung Park1,2
1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
甲德单剂疗法在克罗恩氏病 (CD) 维持过程中显示出有效性和耐受性. 亲肠道给药和较高的基线血红蛋白水平与CD患者更好的临床和内镜结果相关.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲德单独治疗是克罗恩病 (CD) 推的维持疗法.
- 关于其有效性和耐受性的长期随访数据有限.
- 这项研究解决了对长期结果更多数据的需求.
研究的目的:
- 在克罗恩氏病患者中评估甲铁沙单一治疗的有效性和耐受性.
- 确定与长期临床和内镜缓解相关的因素.
- 提供来自韩国炎症肠病 (IBD) 诊所的真实数据.
主要方法:
- 一个多中心的回顾性观察性研究,涉及94名CD患者.
- 甲托雷克萨特是通过口服或直肠道给予的.
- 临床,实验室 (CRP) 和内镜指数在基线和长达24个月的时间被评估.
- 统计分析发现了缓解的独立因素.
主要成果:
- 观察到高临床缓解率:76.3%在6个月,74.6%在12个月,80.0%在24个月.
- 平均CRP水平随着时间的推移显著下降.
- 在38.7%的患者中实现了内镜缓解.
- 门用甲状腺素的使用与更好的临床和内镜缓解有关.
- 低基线血红蛋白 (<10 g/dL) 与临床缓解有负相关性.
结论:
- 甲德单一治疗是克罗恩病的有效和耐受的维持治疗方法.
- 通过肠道给药和适当的血红蛋白水平对于达到缓解是很重要的.
- 进一步的研究可以优化在CD管理中使用甲状腺素.
更多相关视频
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
07:38Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
Published on: September 13, 2016
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
